Gene therapy for prostate cancer at the University of California, Los Angeles: Preliminary results and future directions

Allan J. Pantuck, Aninon Zisman, Arie S. Belldegrun

Research output: Contribution to journalArticlepeer-review

Abstract

The treatment options for patients with advanced prostate cancer are limited. Because of recent advances in the understanding of the molecular biology of prostate cancer, the accessibility of the prostate for injection, and the availability of gene promotors that allow tissue-specific expression of therapeutic gene products, gene therapy for prostate cancer has realized significant achievements in recent years. What once belonged to the realm of basic science is now entering the domain of phase II clinical trials. In this review, current results and future directions in prostate gene therapy at the University of California, Los Angeles, are discussed.

Original languageEnglish
Pages (from-to)143-147
Number of pages5
JournalWorld Journal of Urology
Volume18
Issue number2
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Gene therapy for prostate cancer at the University of California, Los Angeles: Preliminary results and future directions'. Together they form a unique fingerprint.

Cite this